LHC
GILD icon

Little House Capital’s Gilead Sciences GILD Stock Holding History

Little House Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,118
Closed -$662K – 138
2021
Q4 		$662K Buy
9,118
+999
+12% +$68.8K 0.35% 84
2021
Q3 		$567K Buy
8,119
+1,159
+17% +$81.4K 0.33% 86
2021
Q2 		$479K Buy
+6,960
New +$465K 0.26% 99
2019
Q2 		– Sell
-660
Closed -$42K – 163
2019
Q1 		$42K Buy
+660
New +$43.9K 0.03% 172

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Little House Capital's GILD Position: Q1 2022 in Review

Little House Capital sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 9,118 shares — an estimated $662K sold.

Little House Capital first reported a position in GILD in Q1 2019 and held it in 4 quarters. The position peaked at $662K in Q4 2021. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Little House Capital reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • Little House Capital sold 9,118 Gilead Sciences shares in Q1 2022, an estimated $662K.
  • Little House Capital first reported a position in Gilead Sciences in Q1 2019 and held it in 4 quarters.
  • Little House Capital's Gilead Sciences position peaked at $662K in Q4 2021.
  • 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Little House Capital's 13F filing for Q1 2022, filed 16 May 2022.